Neuropathic pain is a chronic and debilitating condition that impacts around 10% of the population in both the United States and Europe. Despite advances in understanding the mechanisms of neuropathic ...

ITDD helps effectively manage chronic pain and spasticity in some patients but requires adherence to best practices and a ...

Injectable biologics may provide superior analgesia, functionality, and QOL vs conventional approaches to chronic pain, ...

"And this results in a very intense pain which has very few treatment options." Earlier this year, the team published a review looking into existing treatments for chronic neuropathic pain and ...

Neuropathic pain is nerve pain that occurs when your nervous system fails or gets damaged. According to studies, this pain can be felt differently from other kinds of pain. Hina Khan is battling with ...

Neuropathic pain affects more than 20 million people in the U.S., and at least a quarter of these cases are puzzling for ...

European researchers have mapped the most comprehensive phenotyping of neuropathic ... pain and identified genetic markers associated with this serious condition. Long-term, low-dose antiviral ...

European researchers have mapped the most comprehensive phenotyping of neuropathic ... pain. People with a genetic variant in opioid receptors may need higher doses of painkillers for the ...

The new preclinical data show that Ketamir-2 is 60% more effective than the FDA-approved neuropathic pain treatment gabapentin in reducing chemotherapy-induced pain. The study used the paclitaxel ...

At present, the impact of the pharmacogenetics on the response to treatment in neuropathic pain is poorly known, but several polymorphisms, among them the cytochrome P450 (CYP)2D6, may intervene.

A recent study has raised concerns about the widespread prescription of antidepressants for chronic pain, warning that many ...